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Summary
The genetically anemic W/W° mice are characterized by the inability of their bone marrow
cells to form macroscopic pluripotent hematopoietic colonies in the spleen ofirradiated recipients
upon transfer (colony-forming units). Furthermore, they almost totally lack mast cells, notably
in the skin. In the present study, we have tested the effect of recombinant murine interleukin
3 (rmIIr3) on W/W° mice hematopoiesis. Transfer of W/W° bone marrow cells into lethally
irradiated recipients perfused with rmIlr3 is followed by the appearance of macroscopic spleen
colonies. Moreover, perfusion of rmIL3 in W/W° mice: (a) restores almost normal total
numbers ofhematopoietic precursors (colony-forming cells), but without modification of anemia;
and (b) leads to the appearance of a normal number of mastocytes in the skin.
T
he W° mutation at the W locus is characterized among
other features by a macrocytic anemia, a total absence
of mature subcutaneous mast cells, a low resistance to irradi-
ation, and the inability ofbone marrow cellsto form macro-
scopic hematopoietic colonies in the spleen oflethally irradi-
ated recipients (CFUs). That all these features result from
the existence of a hematopoietic cell defect is shown by the
fact that bone marrow transplantation from histocompatible
+/+ mice results in a complete and permanent cure of these
hematopoietic alterations (for review, see reference 1).
These and other abnormalities present in these mice
(deficiency in the production of germ cells and melanoblasts
resulting, respectively, in sterility and absence of coat pig-
mentation) appear to result from a defect in the c-kit proto-
oncogene, the product of which is a membrane receptor with
a structure very close to that of the macrophage CSF (M-
CSF) (2, 3), which acts on macrophages and theirprecursors.
Since we have previously observed that perfusion of recom-
binant murine IIr3 (rmID3) increases hematopoiesis in all
myeloid lineages, as well as mast cells (4), we explored the
effect of rmIIr3 perfusion on W/W° mice.
Materials and Methods
Cell Suspensions and Culture
￿
Spleen and bone marrow cells were
obtained as previously described (4). Nonparenchymatous hepatic
cells were obtained according to Wiltroot's technique (5). The
colony-forming cell assay(CFC) was performedin 35-mmdiameter
petri dishes (Greiner, Nurtingen, FRG) using 0.8% methylcellu-
lose (Methocel Fluka AG, Buchs, Switzerland), according to Ehason
et al. (6), with a 10% FCS concentration (Seromed Fakola AG,
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Basel Switzerland) instead of purified BSA. rmIL3 (4) was used
at a supraoptimal concentration of 450 U/ml (unless otherwise
stated); erythropoietin step Il (EPO) (CaunaughtLaboratories, Van-
couver, Canada) was added at a final concentration of 3 U/ml.
Plating concentrations were 2.5 x 10' for bone marrow and 101
cells/ml for the spleen and liver. CFC were identified and scored
with a grid under phase contrast using an inverted microscope with
a 6.3 or 10x objective.
Mice and l+rfusion.
￿
WBB6F1W/W° mice (W/W'), W°/+
heterozygotes, and normal WBB6Fr+/+ (+/+) littermates were
obtained from The Jackson Laboratory (Bar Harbor, ME). Adult
males and females, 12-36 wk old, were used. Alzet mini-osmotic
pumps (2002; Alza Corp., Palo Alto, CA) were placed intraperi-
toneally. The pumps contained either purified rmIL3 at concen-
trations ranging from 112 to 220 ug/liter) or control solution con-
sisting of the same solvent (10% glycerolin PBS) with 1-5 ng LPS/
ml, as previouslydescribed (4). Animals were killed after 13-19 d.
In the case of the 28-d perfusion, a second pump was placed sub-
cutaneously after 14 d.
Spleen CFU Assay.
￿
101 W/W° bone marrow cells were in-
jected intravenously in 17-wk-old W/+ mice that had been lethally
irradiated (1,000 rad from a "'Cs source). Two groups were in-
jected, one without treatment, and another receiving rmIL3 sub-
cutaneously for 8 d (27 Ag/mouse; Alzet 2001; Alza Corp.). Mice
were killed at day 10. Colonies were scored after fixation in Bonin's
solution. Histological sections were examined after hematoxylin-
eosin staining.
Preparation ofSpleen Cell Supernatants.
￿
Spleen cells at a concen-
tration of 5 x 106 cells/ml were incubated for 24 or 48 h with
or without Con A (5 Fig/ml) in DME containing 2% FCS. Super-
natants were centrifuged and filtered through a filter (0.22-ju pore
size) before being tested on an IL3-dependent cell line for quan-
tification of IL3 production (7).
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paraffin-embedded sections was performed after fixation ofthe skin
in neutral formol. Sections were stained with toluidine blue and
alcian blue 8 GX-safranin O (8). Mast cells were scored in 10 different
fields (0.04 mm).
Results
11,3 Perfusion Stimulates Hematopoiesis in W/W° Mice but
Does Not Improve the Anemia. After 13-19d of rmIL-3 per-
fusion in W/W° and +/+, the spleen was enlarged, and
numerous hematopoietic foci were observed on histological
sections of spleen and liver, as already reported for normal
mice (4) . To quantify this hematopoietic enhancement, CFC
assays were performed with bone marrow, spleen, and non-
parenchymatous livercells. As previously observed (4), rmIIr3
perfusion resulted in a shift of hematopoiesis from the bone
marrow to the spleen and liver, where the number of CFC
was massively augmented (Table 1). However, due to the fact
that splenic and hepatic contribution to hematopoiesis is low
when compared with that of bone marrow, rrnIIr3 induced
only a modest calculated enhancement of total hematopoi-
esis. W/W° mice, which have about four times less splenic
CFC than +/+ mice (Table 1), also showed a considerable
increase in spleen and liverCFC under rmIIr3 perfusion, with
a total amount of CFC reaching a value close to that ob-
served in normal micewithout IIr3. Using supraoptimal doses
ofrmIIr3 and EPO for the in vitro assay, the increase in early
erythropoietic precursors (BFU-E) per spleen was comparable
in +/+ and W/W° mice (6 vs. 174 x 103 and 2 vs. 64 x
103 per spleen in each strain of mice, respectively). However,
total BFU-E enhancement per mouse, calculated as in Table
1, was moderate. Since in previous experiments rmIIr3 per-
fusion in normal mice increases the total BFU-E rather than
the CFU-E content, CFU-E were not determined in the
Table 1.
￿
Elects of IL-3 Perfusion on Hematopoietic Progenitors
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Numbers in parentheses indicate numbers of experiments. Each experiment consisted of two to three cultures from two to three mice for each
condition. Total number of CFC (erythroid + nonerythroid) was scored on day 9-11.
Based on the assumption that one femur contains 5% of total bone marrow. Total bone marrow, total splenic, and total hepatic CFC were
added.
Interleukin 3 Perfusion in Anemic Mice
present experiments, No improvement in the anemia was ob-
served: the number of RBC per ml ofblood was 5.0 ± 0.5 x
109 and 5.2 ± 0.2 x 109 in PBS and IL3 treated W/W°
mice, and 9.0 ± 0.3 x 109 and 8.3 ± 0.4 x 109 in com-
parable groups of +/+ mice (mean ± SEM of four experi-
ments with two or three mice in each group) . Even when
rmIL 3 perfusion was prolonged for 28 d, the RBC number
and the hematocrit of the W/W° did not change (29 ± 2
vs. 30 ± 1% for untreated mice) . In contrast, rrnIIr3 perfu-
sion had a marked effect on leukocytosis, which increased
about six times (23 ± 13 x 106 vs. 38 ± 15 x 106 cells/ml
for the W/W° and +/+ mice, respectively); this increase
consisted in large part of polymorphonuclear cells: 36 ± 10
and 57 ± 3% for the W/W° and +/+, respectively (per-
cent of PMN relative to total white blood cells in untreated
animals ranged between 11 and 20).
W/W° Bone Marrow Cells Give Rise to Macroscopic Colo-
nies When Injected into Recipients Perfused with 11,3. When
irradiated recipients of W/W° bone marrow cells were per-
fused with rmIL3 for 8 d after transfer, macroscopic colo-
nies, undetectable without rrnIIr3 perfusion, were observed
on the 10th day (Fig. 1) . Histologically, these colonies were
not distinguishable when compared with those observed in
+/+ irradiated mice injected with +/+ bone marrow cells,
in particular with respect to their content in erythroid cells,
all types of hematopoietic cells being observed. However, in
this assay, the number of bone marrow-derived CFUs from
W/W° mice was deficient, since 6 ± 2 CFUs per 105 in-
jected W/W° bone marrow cells were recovered, compared
with 54 ± 10 CFUs scored for the same number of +/+
bone marrow cells injected to unperfused mice.
11,3 Perfusion Corrects the Cutaneous Mast Cell Depletion of
WlW° Mice. After 28 d of rmIIr3 perfusion, mature cuta-
neous mast cells, which cannot be detected on skin sections
of untreated W/W° mice, were almost as numerous as in
IL-3 (450 U/ml) + EPO (3 U/ml)
Organ
PBS-perfused
CFC/organ
IL-3-perfused
CFC/organ
PBS-perfused
CFC/organ
W/W°
IL-3-perfused
CFC/organ
x 103
Femur 61 (4) 22 (2) 43 (6) 32 (4)
Spleen 71 (3) 948 (3) 14 (4) 429 (4)
Liver 0.6 (1) 27 (1) 0.06 (2) 58 (2)
Total per mouse 1,292" 1,415" 874' 1,127'Figure 1 .
￿
Spleens of lethally irradiated +/+ mice after transfer of
W/W° bone marrow cells (x10) . (A) Under rmIL3 perfusion for 8
d, there is the presence of macroscopic colonies . (B) Without 11,3
(osmotic pumps with solvent alone), no colonies are seen .
the skin ofuntreated +/+ mice : 10.5 ± 0.7 per microscopic
field (0.02 mmz), compared with 14.5 ± 3.5 in +/+ mice
and 23 ± 5 in rmIIJ3-treated +/+ mice (Fig. 2) . These cells
stain positively with safranin, indicating that they are indeed
of the serosal type.
W/W° Mice Have No Defect in Responsiveness to, and in
Production of, IL3. In a CFC assay, no difference in dose-
response to rmI1r3 was detected between bone marrow cells
of W/W° and +/+ mice over a range of concentrations
varying between 2,250 and 0.23 U/ml . The in vitro release
of IL3 by spleen cells ofW/W° or +/+ mice stimulated by
Con A for 24 or 48 h was also found very similar (data not
shown) .
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Discussion
Two striking effects of prolongedrmIL3 perfusion on the
hematopoietic defects ofW/W° mice were observed in the
present study: (a) the restoration of the capacity of early he-
matopoietic progenitors to undergo, in the spleen of irradi-
ated recipients perfused withrmM3, the proliferative expan-
sion giving rise to macroscopic multilineage hematopoietic
colonies ; and (b) the restoration of subcutaneous mast cells,
the bone marrow origin of which is known (9) . In culture,
11,3 allows the growth ofmucosal mast cells, but it has been
shown by transfer experiments that the mucosal or connec-
tive tissue mast cell phenotype is regulated by the tissue
microenvironment ; thus, it is not surprising that these re-
stored cutaneous mast cells were stained by safranin, a char-
acteristic of connective tissue mast cells (10) . A similar ob-
servation has been made in the skin of aged W/Wv mice of
C57L/6 genetic backgroundwhen they develop a dermatitis
in which mast cells progressively accumulate (11) .
On the other hand, in spite of an enhancement in the
number of early erythropoietic precursors (BFU-E), IL3 per-
fusion, even prolonged during 4 wk, failed to significantly
correct the anemia ofW/WI mice. This indicates that the
anemia does not only result from an insufficient expansion
of early erythropoietic precursors. It is unlikely, however, to
simply reflect a relative lack of erythropoietin required for
the final maturation ofBFU-E progeny, since W/W° mice
have high erythropoietin levels .
IL3 does not interact with the c-kit receptor, which is ab-
sent or defective in W/W° mice, since the bone marrow he-
matopoietic progenitors ofW/W° or +/+ mice display the
same response in vitro to a wide range of IL3 concentration;
the gene of the mouse IL3-R has recently been cloned (12),
and it is totally unrelated to the c-kit gene. The ligand of
the c-kit receptor is still unknown ; it appears to be released
or presented, among other sources, by cells of the bone marrow
stroma and by spleen fibroblasts (13, 14) . It is the lack of
Figure 2 .
￿
Mast cells are absent from
the skin of untreated W/W , mice. (A),
but are present after rmIL3 perfusion (28
d) (B) . (toluidine blue staining; x200) .this ligand that is likely to characterize the S1/Sld mutant
mice, which are phenotypically identical to W/W° mice,
but which contain early hematopoietic progenitors giving
rise to normal macroscopic colonies when injected into ir-
radiated +/+ mice, or into W/W° mice, curing their anemia
and their mast cell defect (1). Thus, it appears that, in the
mouse, at least two hematopoietic growth factors promote
the expansion and pluripotent differentiation of early hema-
topoietic progenitors: I1r3, which may not be involved in
basal hematopoiesis since lymphocytes are its major source,
and the ligand of the c-kit receptor, a soluble, membrane-
bound or matrice-bound growth factor that, in some way,
is also necessary for complete RBC maturation.
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